Poseida Therapeutics, Inc. (PSTX)

Poseida Therapeutics Revenue

Poseida Therapeutics had revenue of $82.50M in the twelve months ending March 31, 2024, down -40.82% year-over-year. Revenue in the quarter ending March 31, 2024 was $28.14M with 172.09% year-over-year growth. In the year 2023, Poseida Therapeutics had annual revenue of $64.70M, a decrease of -50.42%.

• Revenue (ttm): $82.50M
• Revenue Growth: -40.82%
• P/S Ratio: 3.76
• Revenue / Employee: $250,006
• Employees: 330
• Market Cap: 310.26M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	64.70M	-65.79M	-50.42%
Dec 31, 2022	130.49M	99.25M	317.73%
Dec 31, 2021	31.24M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.